Search Results

Filter
  • 1-10 of  164,273 results for ""Antineoplastic Combined Chemotherapy Protocols""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group.

  • Authors : Freyer G; Department of Medical Oncology, Lyon 1 University, Lyon, France. .; GINECO (Groupe d'Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire, Paris, France. .

Subjects: Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/drug therapy ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects; Female

  • Source: Nature communications [Nat Commun] 2024 Mar 05; Vol. 15 (1), pp. 1985. Date of Electronic Publication: 2024 Mar 05.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Is the "P-value" Alone a Sufficient Metric for the Magnitude of Clinical Benefit and Which Clinical Trial Is Actually Positive, KEYNOTE-394 or KEYNOTE-240?

  • Authors : Kus T; Department of Medical Oncology, School of Medicine, Gaziantep University, Gaziantep, Turkey.; Aktas G

Subjects: Antineoplastic Combined Chemotherapy Protocols* ; Clinical Trials as Topic*; Humans

  • Source: The oncologist [Oncologist] 2024 Mar 04; Vol. 29 (3), pp. 190-191.Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study.

  • Authors : Theijse RT; Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam, The Netherlands.

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/drug therapy ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/surgery

  • Source: The British journal of surgery [Br J Surg] 2024 Mar 02; Vol. 111 (3).Publisher: Oxford University Press Country of Publication: England NLM ID: 0372553 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Innovative Nanoparticulate Strategies in Colon Cancer Treatment: A Paradigm Shift.

  • Authors : Yadav R; Pharmaceutical Nanotechnology Research Laboratory, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Hyderabad, Telangana, 500 037, India.; Bhawale R

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/pharmacology ; Colonic Neoplasms*/Colonic Neoplasms*/Colonic Neoplasms*/drug therapy; Humans

  • Source: AAPS PharmSciTech [AAPS PharmSciTech] 2024 Mar 01; Vol. 25 (3), pp. 52. Date of Electronic Publication: 2024 Mar 01.Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-9932

Record details

×
Academic Journal

A critical evaluation of the EFS endpoint in AML: Does induction treatment failure timing have a profound impact on study design and results?

  • Authors : Sidi Y; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: .; Dong C

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Leukemia, Myeloid, Acute*; Humans

  • Source: Leukemia research [Leuk Res] 2024 Mar; Vol. 138, pp. 107465. Date of Electronic Publication: 2024 Feb 23.Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Efficacy and Toxicity of Palliative Chemotherapy in Elderly Patients With Advanced Pancreatic Cancer.

  • Authors : Jeong HT; From the Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.; Kim HG

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Gemcitabine*/Gemcitabine*/Gemcitabine*/adverse effects ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/drug therapy

  • Source: Pancreas [Pancreas] 2024 Mar 01; Vol. 53 (3), pp. e268-e273. Date of Electronic Publication: 2024 Feb 01.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8608542 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Low skeletal muscle radiodensity is a risk factor for adjuvant chemotherapy discontinuation in colorectal cancer.

  • Authors : Yokoi K; Department of Lower Gastrointestinal Surgery, Kitasato University School of Medicine, 252-0374, 1-15-1, Kitasato, Minami-Ku, Sagamihara, Kanagawa, Japan.; Watanabe A

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/pathology; Humans

  • Source: International journal of clinical oncology [Int J Clin Oncol] 2024 Mar; Vol. 29 (3), pp. 276-285. Date of Electronic Publication: 2024 Jan 29.Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis.

  • Authors : Piulats JM; Institut Català d'Oncologia, Barcelona; Cancer Immunotherapy Group, OncoBell, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Melanoma* ; Nivolumab* Uveal melanoma

  • Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Mar; Vol. 35 (3), pp. 317-326. Date of Electronic Publication: 2023 Dec 02.Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041

Record details

×
  • 1-10 of  164,273 results for ""Antineoplastic Combined Chemotherapy Protocols""